Care
Christopher Lis, managing director of global healthcare intelligence at J.D. Power, discusses the recent primary care deals by Amazon and CVS Health.
The company will use the funds to advance the study of its neuromodulation device intended to treat Alzheimer's disease.
A study published in The New England Journal of Medicine found a closed-loop control system kept children's glucose levels in the target range longer than standard care.
It also received backing from the founding members of Grab and Zalora.
The acquisition includes Mindstrong's technology assets and some of its employees.
The program will be available through Amwell in the second half of 2023.
It now plans to release more hypnosis-based DTx apps for anxiety, sleep, and chronic pain.
Maven said the acquisition of Naytal will accelerate its growth in the U.K. and Europe.
The company will use the funds to circulate its ArteraAI Prostate Test and to develop tests to support individualized therapy options for other cancers.
The antiviral medication was found to interact with over 2,000 prescription drugs.